Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.34 |
| ▸ | ADH1B | P00325 | 1/20 | 0.34 |
| ▸ | ADH1C | P00326 | 1/20 | 0.34 |
| ▸ | ADH1A | P07327 | 1/20 | 0.34 |
| ▸ | ADH4 | P08319 | 1/20 | 0.34 |
| ▸ | ADH7 | P40394 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 4/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2871557 | 0.94 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1ADH1B | |
| SCHEMBL415427 | 0.94 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1ADH1B | |
| SCHEMBL8141589 | 0.94 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1ADH1B | |
| SCHEMBL1171909 | 0.94 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1ADH1B | |
| SCHEMBL413280 | 0.94 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1ADH1B | |
| SCHEMBL349368 | 0.94 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1ADH1B | |
| SCHEMBL2836084 | 0.94 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1ADH1B | |
| Bromide SCHEMBL5089312 | 0.91 | OPRM1 (0.41) | OPRM1SPHK1LMNADNM1ADH1B | |
| Hydrochloric Acid SCHEMBL3181508 | 0.91 | OPRM1 (0.41) | OPRM1SPHK1LMNADNM1ADH1B | |
| Hydrochloric Acid SCHEMBL5085465 | 0.91 | OPRM1 (0.41) | OPRM1SPHK1LMNADNM1ADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080269526-A1 | METHODS OF MAKING AN ANTISTATIC AGENT | SAIC INNOVATIVE PLASTICS, IP B.V. (NL) | 2008-10-30 | — | — | US | claimed |
| JP-2008519077-A | — | — | 2008-06-05 | — | — | JP | claimed |
| US-20080015377-A1 | METHODS OF MAKING AN ANTISTATIC AGENT | GENERAL ELECTRIC COMPANY (US) | 2008-01-17 | — | — | US | claimed |
| EP-1812502-A2 | METHODS OF MAKING AN ANTISTATIC AGENT | General Electric Company (US) | 2007-08-01 | — | — | EP | claimed |
| WO-2006052522-A2 | METHODS OF MAKING AN ANTISTATIC AGENT | GENERAL ELECTRIC COMPANY (US) | 2006-05-18 | — | — | WO | claimed |
| US-20060100327-A1 | Methods of making an antistatic agent | CITIBANK, N.A., AS COLLATERAL AGENT | 2006-05-11 | — | — | US | claimed |
| EP-2632707-B1 | MULTILAYERED CARBONATE SHEETS | TRINSEO EUROPE GMBH (CH) | 2019-04-10 | — | — | EP | disclosed |
| EP-2393658-B1 | TRANSPARENT MULTILAYERED CARBONATE ARTICLES AND METHOD TO MANUFACTURE THEREOF | TRINSEO EUROPE GMBH (CH) | 2016-03-30 | — | — | EP | disclosed |
| US-8900693-B2 | Polycarbonate compositions having infrared absorbance, method of manufacture, and articles prepared therefrom | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2014-12-02 | — | — | US | disclosed |
| EP-1907465-B1 | POLYCARBONATE COMPOSITIONS HAVING INFRARED ABSORBANCE, METHOD OF MANUFACTURE, AND ARTICLES PREPARED THEREFROM | SABIC INNOVATIVE PLASTICS IP (NL) | 2014-07-23 | — | — | EP | disclosed |
| EP-1702001-B1 | WATER RESISTANT PERMANENT ANTISTATIC THERMOPLASTIC COMPOSITION | SABIC INNOVATIVE PLASTICS IP (NL) | 2013-11-20 | — | — | EP | disclosed |
| US-20130251954-A1 | MULTILAYERED CARBONATE SHEETS | STYRON EUROPE GMBH (CH) | 2013-09-26 | — | — | US | disclosed |
| EP-2632707-A1 | MULTILAYERED CARBONATE SHEETS | Styron Europe GmbH (CH) | 2013-09-04 | — | — | EP | disclosed |
| US-20040228141-A1 | Diffuser for flat panel display | GENERAL ELECTRIC COMPANY | 2004-11-18 | — | — | US | disclosed |
| US-RE38530-E1 | Anti-static resin composition containing fluorinated phosphonium sulfonates | GENERAL ELECTRIC COMPANY | 2004-06-08 | — | — | US | disclosed |
| EP-0897950-B1 | Anti-static resin composition | GEN ELECTRIC (US) | 2004-04-07 | — | — | EP | disclosed |
| US-20030065071-A1 | Thermoplastic composition comprising an antistatic activity enhancer and use of such an enhancer | GENERAL ELECTRIC COMPANY | 2003-04-03 | — | — | US | disclosed |
| EP-1256600-A1 | Thermoplastic composition comprising an antistatic activity enhancer and use of such an enhancer | GENERAL ELECTRIC COMPANY (US) | 2002-11-13 | — | — | EP | disclosed |
| US-6194497-B1 | MOLDINGS OF THERMOPLASTIC RESINS | GENERAL ELECTRIC COMPANY | 2001-02-27 | — | — | US | disclosed |
| EP-0897950-A2 | Anti-static resin composition | GENERAL ELECTRIC COMPANY (US) | 1999-02-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080015377-A1 | METHODS OF MAKING AN ANTISTATIC AGENT | GPX1, GPX4, PRDX1 | OPRM1 274/4885SPHK1 770/4885LMNA 3968/4885 |
| US-20080269526-A1 | METHODS OF MAKING AN ANTISTATIC AGENT | PGM2, CA6, NHERF1 | OPRM1 42/4885SPHK1 653/4885LMNA 4473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.